<author><surname>Warburg</surname> <given-names>O</given-names> </author><title>On the origin of cancer cells</title><source>Science</source><year>1956</year><volume>123</volume><fpage>309</fpage><lpage>314</lpage>
<author><surname>Frezza</surname> <given-names>C</given-names> </author><author><surname>Gottlieb</surname> <given-names>E</given-names> </author><title>Mitochondria in cancer: not just innocent bystanders</title><source>Semin Cancer Biol</source><year>2009</year><volume>19</volume><fpage>4</fpage><lpage>11</lpage>
<author><surname>Tennant</surname> <given-names>DA</given-names> </author><author><surname>Duran</surname> <given-names>RV</given-names> </author><author><surname>Gottlieb</surname> <given-names>E</given-names> </author><title>Targeting metabolic transformation for cancer therapy</title><source>Nat Rev Cancer</source><year>2010</year><volume>10</volume><fpage>267</fpage><lpage>277</lpage>
<author><surname>Kaelin</surname> <given-names>WG</given-names> <suffix>Jr</suffix> </author><title>SDH5 mutations and familial paraganglioma: somewhere Warburg is smiling</title><source>Cancer Cell</source><year>2009</year><volume>16</volume><fpage>180</fpage><lpage>182</lpage>
<author><surname>Frezza</surname> <given-names>C</given-names> </author><author><surname>Tennant</surname> <given-names>DA</given-names> </author><author><surname>Gottlieb</surname> <given-names>E</given-names> </author><title>IDH1 mutations in gliomas: when an enzyme loses its grip</title><source>Cancer Cell</source><year>2010</year><volume>17</volume><fpage>7</fpage><lpage>9</lpage>
<author><surname>Baysal</surname> <given-names>BE</given-names> </author><author><surname>Ferrell</surname> <given-names>RE</given-names> </author><author><surname>Willett-Brozick</surname> <given-names>JE</given-names> </author><author><surname>Lawrence</surname> <given-names>EC</given-names> </author><author><surname>Myssiorek</surname> <given-names>D</given-names> </author><author><surname>Bosch</surname> <given-names>A</given-names> </author><author><surname>Mey</surname> <given-names>A</given-names> </author><author><surname>Taschner</surname> <given-names>PE</given-names> </author><author><surname>Rubinstein</surname> <given-names>WS</given-names> </author><author><surname>Myers</surname> <given-names>EN</given-names> </author><author><surname>Richard</surname> <given-names>CW</given-names> <suffix>3rd</suffix> </author><author><surname>Cornelisse</surname> <given-names>CJ</given-names> </author><author><surname>Devilee</surname> <given-names>P</given-names> </author><author><surname>Devlin</surname> <given-names>B</given-names> </author><title>Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma</title><source>Science</source><year>2000</year><volume>287</volume><fpage>848</fpage><lpage>851</lpage>
<author><surname>Niemann</surname> <given-names>S</given-names> </author><author><surname>Muller</surname> <given-names>U</given-names> </author><title>Mutations in SDHC cause autosomal dominant paraganglioma, type 3</title><source>Nat Genet</source><year>2000</year><volume>26</volume><fpage>268</fpage><lpage>270</lpage>
<author><surname>Astuti</surname> <given-names>D</given-names> </author><author><surname>Latif</surname> <given-names>F</given-names> </author><author><surname>Dallol</surname> <given-names>A</given-names> </author><author><surname>Dahia</surname> <given-names>PL</given-names> </author><author><surname>Douglas</surname> <given-names>F</given-names> </author><author><surname>George</surname> <given-names>E</given-names> </author><author><surname>Skoldberg</surname> <given-names>F</given-names> </author><author><surname>Husebye</surname> <given-names>ES</given-names> </author><author><surname>Eng</surname> <given-names>C</given-names> </author><author><surname>Maher</surname> <given-names>ER</given-names> </author><title>Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma</title><source>Am J Hum Genet</source><year>2001</year><volume>69</volume><fpage>49</fpage><lpage>54</lpage>
<author><surname>Hao</surname> <given-names>HX</given-names> </author><author><surname>Khalimonchuk</surname> <given-names>O</given-names> </author><author><surname>Schraders</surname> <given-names>M</given-names> </author><author><surname>Dephoure</surname> <given-names>N</given-names> </author><author><surname>Bayley</surname> <given-names>JP</given-names> </author><author><surname>Kunst</surname> <given-names>H</given-names> </author><author><surname>Devilee</surname> <given-names>P</given-names> </author><author><surname>Cremers</surname> <given-names>CW</given-names> </author><author><surname>Schiffman</surname> <given-names>JD</given-names> </author><author><surname>Bentz</surname> <given-names>BG</given-names> </author><author><surname>Gygi</surname> <given-names>SP</given-names> </author><author><surname>Winge</surname> <given-names>DR</given-names> </author><author><surname>Kremer</surname> <given-names>H</given-names> </author><author><surname>Rutter</surname> <given-names>J</given-names> </author><title>SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma</title><source>Science</source><year>2009</year><volume>325</volume><fpage>1139</fpage><lpage>1142</lpage>
<author><surname>Bayley</surname> <given-names>JP</given-names> </author><author><surname>Kunst</surname> <given-names>HP</given-names> </author><author><surname>Cascon</surname> <given-names>A</given-names> </author><author><surname>Sampietro</surname> <given-names>ML</given-names> </author><author><surname>Gaal</surname> <given-names>J</given-names> </author><author><surname>Korpershoek</surname> <given-names>E</given-names> </author><author><surname>Hinojar-Gutierrez</surname> <given-names>A</given-names> </author><author><surname>Timmers</surname> <given-names>HJ</given-names> </author><author><surname>Hoefsloot</surname> <given-names>LH</given-names> </author><author><surname>Hermsen</surname> <given-names>MA</given-names> </author><author><surname>Suarez</surname> <given-names>C</given-names> </author><author><surname>Hussain</surname> <given-names>AK</given-names> </author><author><surname>Vriends</surname> <given-names>AH</given-names> </author><author><surname>Hes</surname> <given-names>FJ</given-names> </author><author><surname>Jansen</surname> <given-names>JC</given-names> </author><author><surname>Tops</surname> <given-names>CM</given-names> </author><author><surname>Corssmit</surname> <given-names>EP</given-names> </author><author><surname>Knijff</surname> <given-names>P</given-names> </author><author><surname>Lenders</surname> <given-names>JW</given-names> </author><author><surname>Cremers</surname> <given-names>CW</given-names> </author><author><surname>Devilee</surname> <given-names>P</given-names> </author><author><surname>Dinjens</surname> <given-names>WN</given-names> </author><author><surname>Krijger</surname> <given-names>RR</given-names> </author><author><surname>Robledo</surname> <given-names>M</given-names> </author><title>SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma</title><source>Lancet Oncol</source><year>2010</year><volume>11</volume><fpage>366</fpage><lpage>372</lpage>
<author><surname>Burnichon</surname> <given-names>N</given-names> </author><author><surname>Briere</surname> <given-names>JJ</given-names> </author><author><surname>Libe</surname> <given-names>R</given-names> </author><author><surname>Vescovo</surname> <given-names>L</given-names> </author><author><surname>Riviere</surname> <given-names>J</given-names> </author><author><surname>Tissier</surname> <given-names>F</given-names> </author><author><surname>Jouanno</surname> <given-names>E</given-names> </author><author><surname>Jeunemaitre</surname> <given-names>X</given-names> </author><author><surname>Benit</surname> <given-names>P</given-names> </author><author><surname>Tzagoloff</surname> <given-names>A</given-names> </author><author><surname>Rustin</surname> <given-names>P</given-names> </author><author><surname>Bertherat</surname> <given-names>J</given-names> </author><author><surname>Favier</surname> <given-names>J</given-names> </author><author><surname>Gimenez-Roqueplo</surname> <given-names>AP</given-names> </author><title>SDHA is a tumor suppressor gene causing paraganglioma</title><source>Hum Mol Genet</source><year>2010</year><volume>19</volume><fpage>3011</fpage><lpage>3020</lpage>
<author><surname>Housley</surname> <given-names>SL</given-names> </author><author><surname>Lindsay</surname> <given-names>RS</given-names> </author><author><surname>Young</surname> <given-names>B</given-names> </author><author><surname>McConachie</surname> <given-names>M</given-names> </author><author><surname>Mechan</surname> <given-names>D</given-names> </author><author><surname>Baty</surname> <given-names>D</given-names> </author><author><surname>Christie</surname> <given-names>L</given-names> </author><author><surname>Rahilly</surname> <given-names>M</given-names> </author><author><surname>Qureshi</surname> <given-names>K</given-names> </author><author><surname>Fleming</surname> <given-names>S</given-names> </author><title>Renal carcinoma with giant mitochondria associated with germ-line mutation and somatic loss of the succinate dehydrogenase B gene</title><source>Histopathology</source><year>2010</year><volume>56</volume><fpage>405</fpage><lpage>408</lpage>
<author><surname>Ricketts</surname> <given-names>C</given-names> </author><author><surname>Woodward</surname> <given-names>ER</given-names> </author><author><surname>Killick</surname> <given-names>P</given-names> </author><author><surname>Morris</surname> <given-names>MR</given-names> </author><author><surname>Astuti</surname> <given-names>D</given-names> </author><author><surname>Latif</surname> <given-names>F</given-names> </author><author><surname>Maher</surname> <given-names>ER</given-names> </author><title>Germline SDHB mutations and familial renal cell carcinoma</title><source>J Natl Cancer Inst</source><year>2008</year><volume>100</volume><fpage>1260</fpage><lpage>1262</lpage>
<author><surname>Henderson</surname> <given-names>A</given-names> </author><author><surname>Douglas</surname> <given-names>F</given-names> </author><author><surname>Perros</surname> <given-names>P</given-names> </author><author><surname>Morgan</surname> <given-names>C</given-names> </author><author><surname>Maher</surname> <given-names>ER</given-names> </author><title>SDHB-associated renal oncocytoma suggests a broadening of the renal phenotype in hereditary paragangliomatosis</title><source>Fam Can</source><year>2009</year><volume>8</volume><fpage>257</fpage><lpage>260</lpage>
<author><surname>Gottlieb</surname> <given-names>E</given-names> </author><author><surname>Tomlinson</surname> <given-names>IP</given-names> </author><title>Mitochondrial tumour suppressors: a genetic and biochemical update</title><source>Nat Rev Cancer</source><year>2005</year><volume>5</volume><fpage>857</fpage><lpage>866</lpage>
<author><surname>Nederveen</surname> <given-names>FH</given-names> </author><author><surname>Korpershoek</surname> <given-names>E</given-names> </author><author><surname>Lenders</surname> <given-names>JW</given-names> </author><author><surname>Krijger</surname> <given-names>RR</given-names> </author><author><surname>Dinjens</surname> <given-names>WN</given-names> </author><title>Somatic SDHB mutation in an extraadrenal pheochromocytoma</title><source>N Engl J Med</source><year>2007</year><volume>357</volume><fpage>306</fpage><lpage>308</lpage>
<author><surname>Stratakis</surname> <given-names>CA</given-names> </author><author><surname>Carney</surname> <given-names>JA</given-names> </author><title>The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney&#8211;Stratakis syndrome): molecular genetics and clinical implications</title><source>J Intern Med</source><year>2009</year><volume>266</volume><fpage>43</fpage><lpage>52</lpage>
<author><surname>Launonen</surname> <given-names>V</given-names> </author><author><surname>Vierimaa</surname> <given-names>O</given-names> </author><author><surname>Kiuru</surname> <given-names>M</given-names> </author><author><surname>Isola</surname> <given-names>J</given-names> </author><author><surname>Roth</surname> <given-names>S</given-names> </author><author><surname>Pukkala</surname> <given-names>E</given-names> </author><author><surname>Sistonen</surname> <given-names>P</given-names> </author><author><surname>Herva</surname> <given-names>R</given-names> </author><author><surname>Aaltonen</surname> <given-names>LA</given-names> </author><title>Inherited susceptibility to uterine leiomyomas and renal cell cancer</title><source>Proc Natl Acad Sci USA</source><year>2001</year><volume>98</volume><fpage>3387</fpage><lpage>3392</lpage>
<author><surname>Tomlinson</surname> <given-names>IP</given-names> </author><author><surname>Alam</surname> <given-names>NA</given-names> </author><author><surname>Rowan</surname> <given-names>AJ</given-names> </author><author><surname>Barclay</surname> <given-names>E</given-names> </author><author><surname>Jaeger</surname> <given-names>EE</given-names> </author><author><surname>Kelsell</surname> <given-names>D</given-names> </author><author><surname>Leigh</surname> <given-names>I</given-names> </author><author><surname>Gorman</surname> <given-names>P</given-names> </author><author><surname>Lamlum</surname> <given-names>H</given-names> </author><author><surname>Rahman</surname> <given-names>S</given-names> </author><author><surname>Roylance</surname> <given-names>RR</given-names> </author><author><surname>Olpin</surname> <given-names>S</given-names> </author><author><surname>Bevan</surname> <given-names>S</given-names> </author><author><surname>Barker</surname> <given-names>K</given-names> </author><author><surname>Hearle</surname> <given-names>N</given-names> </author><author><surname>Houlston</surname> <given-names>RS</given-names> </author><author><surname>Kiuru</surname> <given-names>M</given-names> </author><author><surname>Lehtonen</surname> <given-names>R</given-names> </author><author><surname>Karhu</surname> <given-names>A</given-names> </author><author><surname>Vilkki</surname> <given-names>S</given-names> </author><author><surname>Laiho</surname> <given-names>P</given-names> </author><author><surname>Eklund</surname> <given-names>C</given-names> </author><author><surname>Vierimaa</surname> <given-names>O</given-names> </author><author><surname>Aittomaki</surname> <given-names>K</given-names> </author><author><surname>Hietala</surname> <given-names>M</given-names> </author><author><surname>Sistonen</surname> <given-names>P</given-names> </author><author><surname>Paetau</surname> <given-names>A</given-names> </author><author><surname>Salovaara</surname> <given-names>R</given-names> </author><author><surname>Herva</surname> <given-names>R</given-names> </author><author><surname>Launonen</surname> <given-names>V</given-names> </author><author><surname>Aaltonen</surname> <given-names>LA</given-names> </author><title>Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer</title><source>Nat Genet</source><year>2002</year><volume>30</volume><fpage>406</fpage><lpage>410</lpage>
<author><surname>Carvajal-Carmona</surname> <given-names>LG</given-names> </author><author><surname>Alam</surname> <given-names>NA</given-names> </author><author><surname>Pollard</surname> <given-names>PJ</given-names> </author><author><surname>Jones</surname> <given-names>AM</given-names> </author><author><surname>Barclay</surname> <given-names>E</given-names> </author><author><surname>Wortham</surname> <given-names>N</given-names> </author><author><surname>Pignatelli</surname> <given-names>M</given-names> </author><author><surname>Freeman</surname> <given-names>A</given-names> </author><author><surname>Pomplun</surname> <given-names>S</given-names> </author><author><surname>Ellis</surname> <given-names>I</given-names> </author><author><surname>Poulsom</surname> <given-names>R</given-names> </author><author><surname>El-Bahrawy</surname> <given-names>MA</given-names> </author><author><surname>Berney</surname> <given-names>DM</given-names> </author><author><surname>Tomlinson</surname> <given-names>IP</given-names> </author><title>Adult leydig cell tumors of the testis caused by germline fumarate hydratase mutations</title><source>J Clin Endocrinol Metab</source><year>2006</year><volume>91</volume><fpage>3071</fpage><lpage>3075</lpage>
<author><surname>Lehtonen</surname> <given-names>HJ</given-names> </author><author><surname>Kiuru</surname> <given-names>M</given-names> </author><author><surname>Ylisaukko-Oja</surname> <given-names>SK</given-names> </author><author><surname>Salovaara</surname> <given-names>R</given-names> </author><author><surname>Herva</surname> <given-names>R</given-names> </author><author><surname>Koivisto</surname> <given-names>PA</given-names> </author><author><surname>Vierimaa</surname> <given-names>O</given-names> </author><author><surname>Aittomaki</surname> <given-names>K</given-names> </author><author><surname>Pukkala</surname> <given-names>E</given-names> </author><author><surname>Launonen</surname> <given-names>V</given-names> </author><author><surname>Aaltonen</surname> <given-names>LA</given-names> </author><title>Increased risk of cancer in patients with fumarate hydratase germline mutation</title><source>J Med Genet</source><year>2006</year><volume>43</volume><fpage>523</fpage><lpage>526</lpage>
<author><surname>Marcucci</surname> <given-names>G</given-names> </author><author><surname>Maharry</surname> <given-names>K</given-names> </author><author><surname>Wu</surname> <given-names>YZ</given-names> </author><author><surname>Radmacher</surname> <given-names>MD</given-names> </author><author><surname>Mrozek</surname> <given-names>K</given-names> </author><author><surname>Margeson</surname> <given-names>D</given-names> </author><author><surname>Holland</surname> <given-names>KB</given-names> </author><author><surname>Whitman</surname> <given-names>SP</given-names> </author><author><surname>Becker</surname> <given-names>H</given-names> </author><author><surname>Schwind</surname> <given-names>S</given-names> </author><author><surname>Metzeler</surname> <given-names>KH</given-names> </author><author><surname>Powell</surname> <given-names>BL</given-names> </author><author><surname>Carter</surname> <given-names>TH</given-names> </author><author><surname>Kolitz</surname> <given-names>JE</given-names> </author><author><surname>Wetzler</surname> <given-names>M</given-names> </author><author><surname>Carroll</surname> <given-names>AJ</given-names> </author><author><surname>Baer</surname> <given-names>MR</given-names> </author><author><surname>Caligiuri</surname> <given-names>MA</given-names> </author><author><surname>Larson</surname> <given-names>RA</given-names> </author><author><surname>Bloomfield</surname> <given-names>CD</given-names> </author><title>IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study</title><source>J Clin Oncol</source><year>2010</year><volume>28</volume><fpage>2348</fpage><lpage>2355</lpage>
<author><surname>Balss</surname> <given-names>J</given-names> </author><author><surname>Meyer</surname> <given-names>J</given-names> </author><author><surname>Mueller</surname> <given-names>W</given-names> </author><author><surname>Korshunov</surname> <given-names>A</given-names> </author><author><surname>Hartmann</surname> <given-names>C</given-names> </author><author><surname>Deimling</surname> <given-names>A</given-names> </author><title>Analysis of the IDH1 codon 132 mutation in brain tumors</title><source>Acta Neuropathol</source><year>2008</year><volume>116</volume><fpage>597</fpage><lpage>602</lpage>
<author><surname>Parsons</surname> <given-names>DW</given-names> </author><author><surname>Jones</surname> <given-names>S</given-names> </author><author><surname>Zhang</surname> <given-names>X</given-names> </author><author><surname>Lin</surname> <given-names>JC</given-names> </author><author><surname>Leary</surname> <given-names>RJ</given-names> </author><author><surname>Angenendt</surname> <given-names>P</given-names> </author><author><surname>Mankoo</surname> <given-names>P</given-names> </author><author><surname>Carter</surname> <given-names>H</given-names> </author><author><surname>Siu</surname> <given-names>IM</given-names> </author><author><surname>Gallia</surname> <given-names>GL</given-names> </author><author><surname>Olivi</surname> <given-names>A</given-names> </author><author><surname>McLendon</surname> <given-names>R</given-names> </author><author><surname>Rasheed</surname> <given-names>BA</given-names> </author><author><surname>Keir</surname> <given-names>S</given-names> </author><author><surname>Nikolskaya</surname> <given-names>T</given-names> </author><author><surname>Nikolsky</surname> <given-names>Y</given-names> </author><author><surname>Busam</surname> <given-names>DA</given-names> </author><author><surname>Tekleab</surname> <given-names>H</given-names> </author><author><surname>Diaz</surname> <given-names>LA</given-names> <suffix>Jr</suffix> </author><author><surname>Hartigan</surname> <given-names>J</given-names> </author><author><surname>Smith</surname> <given-names>DR</given-names> </author><author><surname>Strausberg</surname> <given-names>RL</given-names> </author><author><surname>Marie</surname> <given-names>SK</given-names> </author><author><surname>Shinjo</surname> <given-names>SM</given-names> </author><author><surname>Yan</surname> <given-names>H</given-names> </author><author><surname>Riggins</surname> <given-names>GJ</given-names> </author><author><surname>Bigner</surname> <given-names>DD</given-names> </author><author><surname>Karchin</surname> <given-names>R</given-names> </author><author><surname>Papadopoulos</surname> <given-names>N</given-names> </author><author><surname>Parmigiani</surname> <given-names>G</given-names> </author><author><surname>Vogelstein</surname> <given-names>B</given-names> </author><author><surname>Velculescu</surname> <given-names>VE</given-names> </author><author><surname>Kinzler</surname> <given-names>KW</given-names> </author><title>An integrated genomic analysis of human glioblastoma multiforme</title><source>Science</source><year>2008</year><volume>321</volume><fpage>1807</fpage><lpage>1812</lpage>
<author><surname>Bleeker</surname> <given-names>FE</given-names> </author><author><surname>Lamba</surname> <given-names>S</given-names> </author><author><surname>Leenstra</surname> <given-names>S</given-names> </author><author><surname>Troost</surname> <given-names>D</given-names> </author><author><surname>Hulsebos</surname> <given-names>T</given-names> </author><author><surname>Vandertop</surname> <given-names>WP</given-names> </author><author><surname>Frattini</surname> <given-names>M</given-names> </author><author><surname>Molinari</surname> <given-names>F</given-names> </author><author><surname>Knowles</surname> <given-names>M</given-names> </author><author><surname>Cerrato</surname> <given-names>A</given-names> </author><author><surname>Rodolfo</surname> <given-names>M</given-names> </author><author><surname>Scarpa</surname> <given-names>A</given-names> </author><author><surname>Felicioni</surname> <given-names>L</given-names> </author><author><surname>Buttitta</surname> <given-names>F</given-names> </author><author><surname>Malatesta</surname> <given-names>S</given-names> </author><author><surname>Marchetti</surname> <given-names>A</given-names> </author><author><surname>Bardelli</surname> <given-names>A</given-names> </author><title>IDH1 mutations at residue p.R132 (IDH1R132) occur frequently in high-grade gliomas but not in other solid tumors</title><source>Hum Mutat</source><year>2009</year><volume>30</volume><fpage>7</fpage><lpage>11</lpage>
<author><surname>Yan</surname> <given-names>H</given-names> </author><author><surname>Parsons</surname> <given-names>DW</given-names> </author><author><surname>Jin</surname> <given-names>G</given-names> </author><author><surname>McLendon</surname> <given-names>R</given-names> </author><author><surname>Rasheed</surname> <given-names>BA</given-names> </author><author><surname>Yuan</surname> <given-names>W</given-names> </author><author><surname>Kos</surname> <given-names>I</given-names> </author><author><surname>Batinic-Haberle</surname> <given-names>I</given-names> </author><author><surname>Jones</surname> <given-names>S</given-names> </author><author><surname>Riggins</surname> <given-names>GJ</given-names> </author><author><surname>Friedman</surname> <given-names>H</given-names> </author><author><surname>Friedman</surname> <given-names>A</given-names> </author><author><surname>Reardon</surname> <given-names>D</given-names> </author><author><surname>Herndon</surname> <given-names>J</given-names> </author><author><surname>Kinzler</surname> <given-names>KW</given-names> </author><author><surname>Velculescu</surname> <given-names>VE</given-names> </author><author><surname>Vogelstein</surname> <given-names>B</given-names> </author><author><surname>Bigner</surname> <given-names>DD</given-names> </author><title>IDH1 and IDH2 mutations in gliomas</title><source>N Engl J Med</source><year>2009</year><volume>360</volume><fpage>765</fpage><lpage>773</lpage>
<author><surname>Dang</surname> <given-names>L</given-names> </author><author><surname>White</surname> <given-names>DW</given-names> </author><author><surname>Gross</surname> <given-names>S</given-names> </author><author><surname>Bennett</surname> <given-names>BD</given-names> </author><author><surname>Bittinger</surname> <given-names>MA</given-names> </author><author><surname>Driggers</surname> <given-names>EM</given-names> </author><author><surname>Fantin</surname> <given-names>VR</given-names> </author><author><surname>Jang</surname> <given-names>HG</given-names> </author><author><surname>Jin</surname> <given-names>S</given-names> </author><author><surname>Keenan</surname> <given-names>MC</given-names> </author><author><surname>Marks</surname> <given-names>KM</given-names> </author><author><surname>Prins</surname> <given-names>RM</given-names> </author><author><surname>Ward</surname> <given-names>PS</given-names> </author><author><surname>Yen</surname> <given-names>KE</given-names> </author><author><surname>Liau</surname> <given-names>LM</given-names> </author><author><surname>Rabinowitz</surname> <given-names>JD</given-names> </author><author><surname>Cantley</surname> <given-names>LC</given-names> </author><author><surname>Thompson</surname> <given-names>CB</given-names> </author><author><surname>Vander Heiden</surname> <given-names>MG</given-names> </author><author><surname>Su</surname> <given-names>SM</given-names> </author><title>Cancer-associated IDH1 mutations produce 2-hydroxyglutarate</title><source>Nature</source><year>2009</year><volume>462</volume><fpage>739</fpage><lpage>744</lpage>
<author><surname>Gimenez-Roqueplo</surname> <given-names>AP</given-names> </author><author><surname>Favier</surname> <given-names>J</given-names> </author><author><surname>Rustin</surname> <given-names>P</given-names> </author><author><surname>Mourad</surname> <given-names>JJ</given-names> </author><author><surname>Plouin</surname> <given-names>PF</given-names> </author><author><surname>Corvol</surname> <given-names>P</given-names> </author><author><surname>Rotig</surname> <given-names>A</given-names> </author><author><surname>Jeunemaitre</surname> <given-names>X</given-names> </author><title>The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway</title><source>Am J Hum Genet</source><year>2001</year><volume>69</volume><fpage>1186</fpage><lpage>1197</lpage>
<author><surname>Dahia</surname> <given-names>PL</given-names> </author><author><surname>Ross</surname> <given-names>KN</given-names> </author><author><surname>Wright</surname> <given-names>ME</given-names> </author><author><surname>Hayashida</surname> <given-names>CY</given-names> </author><author><surname>Santagata</surname> <given-names>S</given-names> </author><author><surname>Barontini</surname> <given-names>M</given-names> </author><author><surname>Kung</surname> <given-names>AL</given-names> </author><author><surname>Sanso</surname> <given-names>G</given-names> </author><author><surname>Powers</surname> <given-names>JF</given-names> </author><author><surname>Tischler</surname> <given-names>AS</given-names> </author><author><surname>Hodin</surname> <given-names>R</given-names> </author><author><surname>Heitritter</surname> <given-names>S</given-names> </author><author><surname>Moore</surname> <given-names>F</given-names> </author><author><surname>Dluhy</surname> <given-names>R</given-names> </author><author><surname>Sosa</surname> <given-names>JA</given-names> </author><author><surname>Ocal</surname> <given-names>IT</given-names> </author><author><surname>Benn</surname> <given-names>DE</given-names> </author><author><surname>Marsh</surname> <given-names>DJ</given-names> </author><author><surname>Robinson</surname> <given-names>BG</given-names> </author><author><surname>Schneider</surname> <given-names>K</given-names> </author><author><surname>Garber</surname> <given-names>J</given-names> </author><author><surname>Arum</surname> <given-names>SM</given-names> </author><author><surname>Korbonits</surname> <given-names>M</given-names> </author><author><surname>Grossman</surname> <given-names>A</given-names> </author><author><surname>Pigny</surname> <given-names>P</given-names> </author><author><surname>Toledo</surname> <given-names>SP</given-names> </author><author><surname>Nose</surname> <given-names>V</given-names> </author><author><surname>Li</surname> <given-names>C</given-names> </author><author><surname>Stiles</surname> <given-names>CD</given-names> </author><title>A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas</title><source>PLoS Genet</source><year>2005</year><volume>1</volume><fpage>72</fpage><lpage>80</lpage>
<author><surname>Vanharanta</surname> <given-names>S</given-names> </author><author><surname>Pollard</surname> <given-names>PJ</given-names> </author><author><surname>Lehtonen</surname> <given-names>HJ</given-names> </author><author><surname>Laiho</surname> <given-names>P</given-names> </author><author><surname>Sjoberg</surname> <given-names>J</given-names> </author><author><surname>Leminen</surname> <given-names>A</given-names> </author><author><surname>Aittomaki</surname> <given-names>K</given-names> </author><author><surname>Arola</surname> <given-names>J</given-names> </author><author><surname>Kruhoffer</surname> <given-names>M</given-names> </author><author><surname>Orntoft</surname> <given-names>TF</given-names> </author><author><surname>Tomlinson</surname> <given-names>IP</given-names> </author><author><surname>Kiuru</surname> <given-names>M</given-names> </author><author><surname>Arango</surname> <given-names>D</given-names> </author><author><surname>Aaltonen</surname> <given-names>LA</given-names> </author><title>Distinct expression profile in fumarate-hydratase-deficient uterine fibroids</title><source>Hum Mol Genet</source><year>2006</year><volume>15</volume><fpage>97</fpage><lpage>103</lpage>
<author><surname>Cervera</surname> <given-names>AM</given-names> </author><author><surname>Apostolova</surname> <given-names>N</given-names> </author><author><surname>Crespo</surname> <given-names>FL</given-names> </author><author><surname>Mata</surname> <given-names>M</given-names> </author><author><surname>McCreath</surname> <given-names>KJ</given-names> </author><title>Cells silenced for SDHB expression display characteristic features of the tumor phenotype</title><source>Cancer Res</source><year>2008</year><volume>68</volume><fpage>4058</fpage><lpage>4067</lpage>
<author><surname>Ashrafian</surname> <given-names>H</given-names> </author><author><surname>O'Flaherty</surname> <given-names>L</given-names> </author><author><surname>Adam</surname> <given-names>J</given-names> </author><author><surname>Steeples</surname> <given-names>V</given-names> </author><author><surname>Chung</surname> <given-names>YL</given-names> </author><author><surname>East</surname> <given-names>P</given-names> </author><author><surname>Vanharanta</surname> <given-names>S</given-names> </author><author><surname>Lehtonen</surname> <given-names>H</given-names> </author><author><surname>Nye</surname> <given-names>E</given-names> </author><author><surname>Hatipoglu</surname> <given-names>E</given-names> </author><author><surname>Miranda</surname> <given-names>M</given-names> </author><author><surname>Howarth</surname> <given-names>K</given-names> </author><author><surname>Shukla</surname> <given-names>D</given-names> </author><author><surname>Troy</surname> <given-names>H</given-names> </author><author><surname>Griffiths</surname> <given-names>J</given-names> </author><author><surname>Spencer-Dene</surname> <given-names>B</given-names> </author><author><surname>Yusuf</surname> <given-names>M</given-names> </author><author><surname>Volpi</surname> <given-names>E</given-names> </author><author><surname>Maxwell</surname> <given-names>PH</given-names> </author><author><surname>Stamp</surname> <given-names>G</given-names> </author><author><surname>Poulsom</surname> <given-names>R</given-names> </author><author><surname>Pugh</surname> <given-names>CW</given-names> </author><author><surname>Costa</surname> <given-names>B</given-names> </author><author><surname>Bardella</surname> <given-names>C</given-names> </author><author><surname>Renzo</surname> <given-names>MF</given-names> </author><author><surname>Kotlikoff</surname> <given-names>MI</given-names> </author><author><surname>Launonen</surname> <given-names>V</given-names> </author><author><surname>Aaltonen</surname> <given-names>L</given-names> </author><author><surname>El-Bahrawy</surname> <given-names>M</given-names> </author><author><surname>Tomlinson</surname> <given-names>I</given-names> </author><author><surname>Pollard</surname> <given-names>PJ</given-names> </author><title>Expression profiling in progressive stages of fumarate-hydratase deficiency: the contribution of metabolic changes to tumorigenesis</title><source>Cancer Res</source><year>2010</year><volume>70</volume><fpage>9153</fpage><lpage>9165</lpage>
<author><surname>Selak</surname> <given-names>MA</given-names> </author><author><surname>Armour</surname> <given-names>SM</given-names> </author><author><surname>MacKenzie</surname> <given-names>ED</given-names> </author><author><surname>Boulahbel</surname> <given-names>H</given-names> </author><author><surname>Watson</surname> <given-names>DG</given-names> </author><author><surname>Mansfield</surname> <given-names>KD</given-names> </author><author><surname>Pan</surname> <given-names>Y</given-names> </author><author><surname>Simon</surname> <given-names>MC</given-names> </author><author><surname>Thompson</surname> <given-names>CB</given-names> </author><author><surname>Gottlieb</surname> <given-names>E</given-names> </author><title>Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase</title><source>Cancer Cell</source><year>2005</year><volume>7</volume><fpage>77</fpage><lpage>85</lpage>
<author><surname>Isaacs</surname> <given-names>JS</given-names> </author><author><surname>Jung</surname> <given-names>YJ</given-names> </author><author><surname>Mole</surname> <given-names>DR</given-names> </author><author><surname>Lee</surname> <given-names>S</given-names> </author><author><surname>Torres-Cabala</surname> <given-names>C</given-names> </author><author><surname>Chung</surname> <given-names>YL</given-names> </author><author><surname>Merino</surname> <given-names>M</given-names> </author><author><surname>Trepel</surname> <given-names>J</given-names> </author><author><surname>Zbar</surname> <given-names>B</given-names> </author><author><surname>Toro</surname> <given-names>J</given-names> </author><author><surname>Ratcliffe</surname> <given-names>PJ</given-names> </author><author><surname>Linehan</surname> <given-names>WM</given-names> </author><author><surname>Neckers</surname> <given-names>L</given-names> </author><title>HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability</title><source>Cancer Cell</source><year>2005</year><volume>8</volume><fpage>143</fpage><lpage>153</lpage>
<author><surname>Pollard</surname> <given-names>PJ</given-names> </author><author><surname>Briere</surname> <given-names>JJ</given-names> </author><author><surname>Alam</surname> <given-names>NA</given-names> </author><author><surname>Barwell</surname> <given-names>J</given-names> </author><author><surname>Barclay</surname> <given-names>E</given-names> </author><author><surname>Wortham</surname> <given-names>NC</given-names> </author><author><surname>Hunt</surname> <given-names>T</given-names> </author><author><surname>Mitchell</surname> <given-names>M</given-names> </author><author><surname>Olpin</surname> <given-names>S</given-names> </author><author><surname>Moat</surname> <given-names>SJ</given-names> </author><author><surname>Hargreaves</surname> <given-names>IP</given-names> </author><author><surname>Heales</surname> <given-names>SJ</given-names> </author><author><surname>Chung</surname> <given-names>YL</given-names> </author><author><surname>Griffiths</surname> <given-names>JR</given-names> </author><author><surname>Dalgleish</surname> <given-names>A</given-names> </author><author><surname>McGrath</surname> <given-names>JA</given-names> </author><author><surname>Gleeson</surname> <given-names>MJ</given-names> </author><author><surname>Hodgson</surname> <given-names>SV</given-names> </author><author><surname>Poulsom</surname> <given-names>R</given-names> </author><author><surname>Rustin</surname> <given-names>P</given-names> </author><author><surname>Tomlinson</surname> <given-names>IP</given-names> </author><title>Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations</title><source>Hum Mol Genet</source><year>2005</year><volume>14</volume><fpage>2231</fpage><lpage>2239</lpage>
<author><surname>Hewitson</surname> <given-names>KS</given-names> </author><author><surname>Lienard</surname> <given-names>BM</given-names> </author><author><surname>McDonough</surname> <given-names>MA</given-names> </author><author><surname>Clifton</surname> <given-names>IJ</given-names> </author><author><surname>Butler</surname> <given-names>D</given-names> </author><author><surname>Soares</surname> <given-names>AS</given-names> </author><author><surname>Oldham</surname> <given-names>NJ</given-names> </author><author><surname>McNeill</surname> <given-names>LA</given-names> </author><author><surname>Schofield</surname> <given-names>CJ</given-names> </author><title>Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates</title><source>J Biol Chem</source><year>2007</year><volume>282</volume><fpage>3293</fpage><lpage>3301</lpage>
<author><surname>MacKenzie</surname> <given-names>ED</given-names> </author><author><surname>Selak</surname> <given-names>MA</given-names> </author><author><surname>Tennant</surname> <given-names>DA</given-names> </author><author><surname>Payne</surname> <given-names>LJ</given-names> </author><author><surname>Crosby</surname> <given-names>S</given-names> </author><author><surname>Frederiksen</surname> <given-names>CM</given-names> </author><author><surname>Watson</surname> <given-names>DG</given-names> </author><author><surname>Gottlieb</surname> <given-names>E</given-names> </author><title>Cell-permeating alpha-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells</title><source>Mol Cell Biol</source><year>2007</year><volume>27</volume><fpage>3282</fpage><lpage>3289</lpage>
<author><surname>Porcelli</surname> <given-names>AM</given-names> </author><author><surname>Ghelli</surname> <given-names>A</given-names> </author><author><surname>Ceccarelli</surname> <given-names>C</given-names> </author><author><surname>Lang</surname> <given-names>M</given-names> </author><author><surname>Cenacchi</surname> <given-names>G</given-names> </author><author><surname>Capristo</surname> <given-names>M</given-names> </author><author><surname>Pennisi</surname> <given-names>LF</given-names> </author><author><surname>Morra</surname> <given-names>I</given-names> </author><author><surname>Ciccarelli</surname> <given-names>E</given-names> </author><author><surname>Melcarne</surname> <given-names>A</given-names> </author><author><surname>Bartoletti-Stella</surname> <given-names>A</given-names> </author><author><surname>Salfi</surname> <given-names>N</given-names> </author><author><surname>Tallini</surname> <given-names>G</given-names> </author><author><surname>Martinuzzi</surname> <given-names>A</given-names> </author><author><surname>Carelli</surname> <given-names>V</given-names> </author><author><surname>Attimonelli</surname> <given-names>M</given-names> </author><author><surname>Rugolo</surname> <given-names>M</given-names> </author><author><surname>Romeo</surname> <given-names>G</given-names> </author><author><surname>Gasparre</surname> <given-names>G</given-names> </author><title>The genetic and metabolic signature of oncocytic transformation implicates HIF1alpha destabilization</title><source>Hum Mol Genet</source><year>2010</year><volume>19</volume><fpage>1019</fpage><lpage>1032</lpage>
<author><surname>Guzy</surname> <given-names>RD</given-names> </author><author><surname>Hoyos</surname> <given-names>B</given-names> </author><author><surname>Robin</surname> <given-names>E</given-names> </author><author><surname>Chen</surname> <given-names>H</given-names> </author><author><surname>Liu</surname> <given-names>L</given-names> </author><author><surname>Mansfield</surname> <given-names>KD</given-names> </author><author><surname>Simon</surname> <given-names>MC</given-names> </author><author><surname>Hammerling</surname> <given-names>U</given-names> </author><author><surname>Schumacker</surname> <given-names>PT</given-names> </author><title>Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing</title><source>Cell Metab</source><year>2005</year><volume>1</volume><fpage>401</fpage><lpage>408</lpage>
<author><surname>Mansfield</surname> <given-names>KD</given-names> </author><author><surname>Guzy</surname> <given-names>RD</given-names> </author><author><surname>Pan</surname> <given-names>Y</given-names> </author><author><surname>Young</surname> <given-names>RM</given-names> </author><author><surname>Cash</surname> <given-names>TP</given-names> </author><author><surname>Schumacker</surname> <given-names>PT</given-names> </author><author><surname>Simon</surname> <given-names>MC</given-names> </author><title>Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-alpha activation</title><source>Cell Metab</source><year>2005</year><volume>1</volume><fpage>393</fpage><lpage>399</lpage>
<author><surname>Guzy</surname> <given-names>RD</given-names> </author><author><surname>Sharma</surname> <given-names>B</given-names> </author><author><surname>Bell</surname> <given-names>E</given-names> </author><author><surname>Chandel</surname> <given-names>NS</given-names> </author><author><surname>Schumacker</surname> <given-names>PT</given-names> </author><title>Loss of the SdhB, but not the SdhA, subunit of complex II triggers ROS-dependent HIF activation and tumorigenesis</title><source>Mol Cell Biol</source><year>2008</year><volume>28</volume><fpage>718</fpage><lpage>731</lpage>
<author><surname>Sudarshan</surname> <given-names>S</given-names> </author><author><surname>Sourbier</surname> <given-names>C</given-names> </author><author><surname>Kong</surname> <given-names>HS</given-names> </author><author><surname>Block</surname> <given-names>K</given-names> </author><author><surname>Valera Romero</surname> <given-names>VA</given-names> </author><author><surname>Yang</surname> <given-names>Y</given-names> </author><author><surname>Galindo</surname> <given-names>C</given-names> </author><author><surname>Mollapour</surname> <given-names>M</given-names> </author><author><surname>Scroggins</surname> <given-names>B</given-names> </author><author><surname>Goode</surname> <given-names>N</given-names> </author><author><surname>Lee</surname> <given-names>MJ</given-names> </author><author><surname>Gourlay</surname> <given-names>CW</given-names> </author><author><surname>Trepel</surname> <given-names>J</given-names> </author><author><surname>Linehan</surname> <given-names>WM</given-names> </author><author><surname>Neckers</surname> <given-names>L</given-names> </author><title>Fumarate hydratase deficiency in renal cancer induces glycolytic addiction and hypoxia-inducible transcription factor 1alpha stabilization by glucose-dependent generation of reactive oxygen species</title><source>Mol Cell Biol</source><year>2009</year><volume>29</volume><fpage>4080</fpage><lpage>4090</lpage>
<author><surname>Selak</surname> <given-names>MA</given-names> </author><author><surname>Duran</surname> <given-names>RV</given-names> </author><author><surname>Gottlieb</surname> <given-names>E</given-names> </author><title>Redox stress is not essential for the pseudo-hypoxic phenotype of succinate dehydrogenase deficient cells</title><source>Biochim Biophys Acta</source><year>2006</year><volume>1757</volume><fpage>567</fpage><lpage>572</lpage>
<author><surname>O'Flaherty</surname> <given-names>L</given-names> </author><author><surname>Adam</surname> <given-names>J</given-names> </author><author><surname>Heather</surname> <given-names>LC</given-names> </author><author><surname>Zhdanov</surname> <given-names>AV</given-names> </author><author><surname>Chung</surname> <given-names>YL</given-names> </author><author><surname>Miranda</surname> <given-names>MX</given-names> </author><author><surname>Croft</surname> <given-names>J</given-names> </author><author><surname>Olpin</surname> <given-names>S</given-names> </author><author><surname>Clarke</surname> <given-names>K</given-names> </author><author><surname>Pugh</surname> <given-names>CW</given-names> </author><author><surname>Griffiths</surname> <given-names>J</given-names> </author><author><surname>Papkovsky</surname> <given-names>D</given-names> </author><author><surname>Ashrafian</surname> <given-names>H</given-names> </author><author><surname>Ratcliffe</surname> <given-names>PJ</given-names> </author><author><surname>Pollard</surname> <given-names>PJ</given-names> </author><title>Dysregulation of hypoxia pathways in fumarate hydratase-deficient cells is independent of defective mitochondrial metabolism</title><source>Hum Mol Genet</source><year>2010</year><volume>19</volume><fpage>3844</fpage><lpage>3851</lpage>
<author><surname>Lee</surname> <given-names>S</given-names> </author><author><surname>Nakamura</surname> <given-names>E</given-names> </author><author><surname>Yang</surname> <given-names>H</given-names> </author><author><surname>Wei</surname> <given-names>W</given-names> </author><author><surname>Linggi</surname> <given-names>MS</given-names> </author><author><surname>Sajan</surname> <given-names>MP</given-names> </author><author><surname>Farese</surname> <given-names>RV</given-names> </author><author><surname>Freeman</surname> <given-names>RS</given-names> </author><author><surname>Carter</surname> <given-names>BD</given-names> </author><author><surname>Kaelin</surname> <given-names>WG</given-names> <suffix>Jr</suffix> </author><author><surname>Schlisio</surname> <given-names>S</given-names> </author><title>Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer</title><source>Cancer Cell</source><year>2005</year><volume>8</volume><fpage>155</fpage><lpage>167</lpage>
<author><surname>Schlisio</surname> <given-names>S</given-names> </author><author><surname>Kenchappa</surname> <given-names>RS</given-names> </author><author><surname>Vredeveld</surname> <given-names>LC</given-names> </author><author><surname>George</surname> <given-names>RE</given-names> </author><author><surname>Stewart</surname> <given-names>R</given-names> </author><author><surname>Greulich</surname> <given-names>H</given-names> </author><author><surname>Shahriari</surname> <given-names>K</given-names> </author><author><surname>Nguyen</surname> <given-names>NV</given-names> </author><author><surname>Pigny</surname> <given-names>P</given-names> </author><author><surname>Dahia</surname> <given-names>PL</given-names> </author><author><surname>Pomeroy</surname> <given-names>SL</given-names> </author><author><surname>Maris</surname> <given-names>JM</given-names> </author><author><surname>Look</surname> <given-names>AT</given-names> </author><author><surname>Meyerson</surname> <given-names>M</given-names> </author><author><surname>Peeper</surname> <given-names>DS</given-names> </author><author><surname>Carter</surname> <given-names>BD</given-names> </author><author><surname>Kaelin</surname> <given-names>WG</given-names> <suffix>Jr</suffix> </author><title>The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor</title><source>Genes Dev</source><year>2008</year><volume>22</volume><fpage>884</fpage><lpage>893</lpage>
<author><surname>Raimundo</surname> <given-names>N</given-names> </author><author><surname>Vanharanta</surname> <given-names>S</given-names> </author><author><surname>Aaltonen</surname> <given-names>LA</given-names> </author><author><surname>Hovatta</surname> <given-names>I</given-names> </author><author><surname>Suomalainen</surname> <given-names>A</given-names> </author><title>Downregulation of SRF-FOS-JUNB pathway in fumarate hydratase deficiency and in uterine leiomyomas</title><source>Oncogene</source><year>2009</year><volume>28</volume><fpage>1261</fpage><lpage>1273</lpage>
<author><surname>Schofield</surname> <given-names>CJ</given-names> </author><author><surname>Ratcliffe</surname> <given-names>PJ</given-names> </author><title>Oxygen sensing by HIF hydroxylases</title><source>Nat Rev Mol Cell Biol</source><year>2004</year><volume>5</volume><fpage>343</fpage><lpage>354</lpage>
<author><surname>Cervera</surname> <given-names>AM</given-names> </author><author><surname>Bayley</surname> <given-names>JP</given-names> </author><author><surname>Devilee</surname> <given-names>P</given-names> </author><author><surname>McCreath</surname> <given-names>KJ</given-names> </author><title>Inhibition of succinate dehydrogenase dysregulates histone modification in mammalian cells</title><source>Mol Cancer</source><year>2009</year><volume>8</volume><fpage>89</fpage>
<author><surname>Smith</surname> <given-names>EH</given-names> </author><author><surname>Janknecht</surname> <given-names>R</given-names> </author><author><surname>Maher</surname> <given-names>LJ</given-names> <suffix>3rd</suffix> </author><title>Succinate inhibition of alpha-ketoglutarate-dependent enzymes in a yeast model of paraganglioma</title><source>Hum Mol Genet</source><year>2007</year><volume>16</volume><fpage>3136</fpage><lpage>3148</lpage>
<author><surname>Teperino</surname> <given-names>R</given-names> </author><author><surname>Schoonjans</surname> <given-names>K</given-names> </author><author><surname>Auwerx</surname> <given-names>J</given-names> </author><title>Histone methyl transferases and demethylases; can they link metabolism and transcription?</title><source>Cell Metab</source><year>2010</year><volume>12</volume><fpage>321</fpage><lpage>327</lpage>
<author><surname>Pollard</surname> <given-names>PJ</given-names> </author><author><surname>Loenarz</surname> <given-names>C</given-names> </author><author><surname>Mole</surname> <given-names>DR</given-names> </author><author><surname>McDonough</surname> <given-names>MA</given-names> </author><author><surname>Gleadle</surname> <given-names>JM</given-names> </author><author><surname>Schofield</surname> <given-names>CJ</given-names> </author><author><surname>Ratcliffe</surname> <given-names>PJ</given-names> </author><title>Regulation of Jumonji-domain-containing histone demethylases by hypoxia-inducible factor (HIF)-1alpha</title><source>Biochem J</source><year>2008</year><volume>416</volume><fpage>387</fpage><lpage>394</lpage>
<author><surname>Beyer</surname> <given-names>S</given-names> </author><author><surname>Kristensen</surname> <given-names>MM</given-names> </author><author><surname>Jensen</surname> <given-names>KS</given-names> </author><author><surname>Johansen</surname> <given-names>JV</given-names> </author><author><surname>Staller</surname> <given-names>P</given-names> </author><title>The histone demethylases JMJD1A and JMJD2B are transcriptional targets of hypoxia-inducible factor HIF</title><source>J Biol Chem</source><year>2008</year><volume>283</volume><fpage>36542</fpage><lpage>36552</lpage>
<author><surname>Yang</surname> <given-names>J</given-names> </author><author><surname>Jubb</surname> <given-names>AM</given-names> </author><author><surname>Pike</surname> <given-names>L</given-names> </author><author><surname>Buffa</surname> <given-names>FM</given-names> </author><author><surname>Turley</surname> <given-names>H</given-names> </author><author><surname>Baban</surname> <given-names>D</given-names> </author><author><surname>Leek</surname> <given-names>R</given-names> </author><author><surname>Gatter</surname> <given-names>KC</given-names> </author><author><surname>Ragoussis</surname> <given-names>J</given-names> </author><author><surname>Harris</surname> <given-names>AL</given-names> </author><title>The histone demethylase JMJD2B is regulated by estrogen receptor alpha and hypoxia, and is a key mediator of estrogen induced growth</title><source>Cancer Res</source><year>2010</year><volume>70</volume><fpage>6456</fpage><lpage>6466</lpage>
<author><surname>He</surname> <given-names>W</given-names> </author><author><surname>Miao</surname> <given-names>FJ</given-names> </author><author><surname>Lin</surname> <given-names>DC</given-names> </author><author><surname>Schwandner</surname> <given-names>RT</given-names> </author><author><surname>Wang</surname> <given-names>Z</given-names> </author><author><surname>Gao</surname> <given-names>J</given-names> </author><author><surname>Chen</surname> <given-names>JL</given-names> </author><author><surname>Tian</surname> <given-names>H</given-names> </author><author><surname>Ling</surname> <given-names>L</given-names> </author><title>Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors</title><source>Nature</source><year>2004</year><volume>429</volume><fpage>188</fpage><lpage>193</lpage>
<author><surname>Peti-Peterdi</surname> <given-names>J</given-names> </author><title>High glucose and renin release: the role of succinate and GPR91</title><source>Kidney Int</source><year>2010</year><volume>78</volume><fpage>1214</fpage><lpage>1217</lpage>
<author><surname>Sapieha</surname> <given-names>P</given-names> </author><author><surname>Sirinyan</surname> <given-names>M</given-names> </author><author><surname>Hamel</surname> <given-names>D</given-names> </author><author><surname>Zaniolo</surname> <given-names>K</given-names> </author><author><surname>Joyal</surname> <given-names>JS</given-names> </author><author><surname>Cho</surname> <given-names>JH</given-names> </author><author><surname>Honore</surname> <given-names>JC</given-names> </author><author><surname>Kermorvant-Duchemin</surname> <given-names>E</given-names> </author><author><surname>Varma</surname> <given-names>DR</given-names> </author><author><surname>Tremblay</surname> <given-names>S</given-names> </author><author><surname>Leduc</surname> <given-names>M</given-names> </author><author><surname>Rihakova</surname> <given-names>L</given-names> </author><author><surname>Hardy</surname> <given-names>P</given-names> </author><author><surname>Klein</surname> <given-names>WH</given-names> </author><author><surname>Mu</surname> <given-names>X</given-names> </author><author><surname>Mamer</surname> <given-names>O</given-names> </author><author><surname>Lachapelle</surname> <given-names>P</given-names> </author><author><surname>Polo</surname> <given-names>A</given-names> </author><author><surname>Beausejour</surname> <given-names>C</given-names> </author><author><surname>Andelfinger</surname> <given-names>G</given-names> </author><author><surname>Mitchell</surname> <given-names>G</given-names> </author><author><surname>Sennlaub</surname> <given-names>F</given-names> </author><author><surname>Chemtob</surname> <given-names>S</given-names> </author><title>The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis</title><source>Nat Med</source><year>2008</year><volume>14</volume><fpage>1067</fpage><lpage>1076</lpage>
<author><surname>Tian</surname> <given-names>Z</given-names> </author><author><surname>Liu</surname> <given-names>Y</given-names> </author><author><surname>Usa</surname> <given-names>K</given-names> </author><author><surname>Mladinov</surname> <given-names>D</given-names> </author><author><surname>Fang</surname> <given-names>Y</given-names> </author><author><surname>Ding</surname> <given-names>X</given-names> </author><author><surname>Greene</surname> <given-names>AS</given-names> </author><author><surname>Cowley</surname> <given-names>AW</given-names> <suffix>Jr</suffix> </author><author><surname>Liang</surname> <given-names>M</given-names> </author><title>Novel role of fumarate metabolism in dahl-salt sensitive hypertension</title><source>Hypertension</source><year>2009</year><volume>54</volume><fpage>255</fpage><lpage>260</lpage>
<author><surname>Mardis</surname> <given-names>ER</given-names> </author><author><surname>Ding</surname> <given-names>L</given-names> </author><author><surname>Dooling</surname> <given-names>DJ</given-names> </author><author><surname>Larson</surname> <given-names>DE</given-names> </author><author><surname>McLellan</surname> <given-names>MD</given-names> </author><author><surname>Chen</surname> <given-names>K</given-names> </author><author><surname>Koboldt</surname> <given-names>DC</given-names> </author><author><surname>Fulton</surname> <given-names>RS</given-names> </author><author><surname>Delehaunty</surname> <given-names>KD</given-names> </author><author><surname>McGrath</surname> <given-names>SD</given-names> </author><author><surname>Fulton</surname> <given-names>LA</given-names> </author><author><surname>Locke</surname> <given-names>DP</given-names> </author><author><surname>Magrini</surname> <given-names>VJ</given-names> </author><author><surname>Abbott</surname> <given-names>RM</given-names> </author><author><surname>Vickery</surname> <given-names>TL</given-names> </author><author><surname>Reed</surname> <given-names>JS</given-names> </author><author><surname>Robinson</surname> <given-names>JS</given-names> </author><author><surname>Wylie</surname> <given-names>T</given-names> </author><author><surname>Smith</surname> <given-names>SM</given-names> </author><author><surname>Carmichael</surname> <given-names>L</given-names> </author><author><surname>Eldred</surname> <given-names>JM</given-names> </author><author><surname>Harris</surname> <given-names>CC</given-names> </author><author><surname>Walker</surname> <given-names>J</given-names> </author><author><surname>Peck</surname> <given-names>JB</given-names> </author><author><surname>Du</surname> <given-names>F</given-names> </author><author><surname>Dukes</surname> <given-names>AF</given-names> </author><author><surname>Sanderson</surname> <given-names>GE</given-names> </author><author><surname>Brummett</surname> <given-names>AM</given-names> </author><author><surname>Clark</surname> <given-names>E</given-names> </author><author><surname>McMichael</surname> <given-names>JF</given-names> </author><author><surname>Meyer</surname> <given-names>RJ</given-names> </author><author><surname>Schindler</surname> <given-names>JK</given-names> </author><author><surname>Pohl</surname> <given-names>CS</given-names> </author><author><surname>Wallis</surname> <given-names>JW</given-names> </author><author><surname>Shi</surname> <given-names>X</given-names> </author><author><surname>Lin</surname> <given-names>L</given-names> </author><author><surname>Schmidt</surname> <given-names>H</given-names> </author><author><surname>Tang</surname> <given-names>Y</given-names> </author><author><surname>Haipek</surname> <given-names>C</given-names> </author><author><surname>Wiechert</surname> <given-names>ME</given-names> </author><author><surname>Ivy</surname> <given-names>JV</given-names> </author><author><surname>Kalicki</surname> <given-names>J</given-names> </author><author><surname>Elliott</surname> <given-names>G</given-names> </author><author><surname>Ries</surname> <given-names>RE</given-names> </author><author><surname>Payton</surname> <given-names>JE</given-names> </author><author><surname>Westervelt</surname> <given-names>P</given-names> </author><author><surname>Tomasson</surname> <given-names>MH</given-names> </author><author><surname>Watson</surname> <given-names>MA</given-names> </author><author><surname>Baty</surname> <given-names>J</given-names> </author><author><surname>Heath</surname> <given-names>S</given-names> </author><author><surname>Shannon</surname> <given-names>WD</given-names> </author><author><surname>Nagarajan</surname> <given-names>R</given-names> </author><author><surname>Link</surname> <given-names>DC</given-names> </author><author><surname>Walter</surname> <given-names>MJ</given-names> </author><author><surname>Graubert</surname> <given-names>TA</given-names> </author><author><surname>DiPersio</surname> <given-names>JF</given-names> </author><author><surname>Wilson</surname> <given-names>RK</given-names> </author><author><surname>Ley</surname> <given-names>TJ</given-names> </author><title>Recurring mutations found by sequencing an acute myeloid leukemia genome</title><source>N Engl J Med</source><year>2009</year><volume>361</volume><fpage>1058</fpage><lpage>1066</lpage>
<author><surname>Gross</surname> <given-names>S</given-names> </author><author><surname>Cairns</surname> <given-names>RA</given-names> </author><author><surname>Minden</surname> <given-names>MD</given-names> </author><author><surname>Driggers</surname> <given-names>EM</given-names> </author><author><surname>Bittinger</surname> <given-names>MA</given-names> </author><author><surname>Jang</surname> <given-names>HG</given-names> </author><author><surname>Sasaki</surname> <given-names>M</given-names> </author><author><surname>Jin</surname> <given-names>S</given-names> </author><author><surname>Schenkein</surname> <given-names>DP</given-names> </author><author><surname>Su</surname> <given-names>SM</given-names> </author><author><surname>Dang</surname> <given-names>L</given-names> </author><author><surname>Fantin</surname> <given-names>VR</given-names> </author><author><surname>Mak</surname> <given-names>TW</given-names> </author><title>Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations</title><source>J Exp Med</source><year>2010</year><volume>207</volume><fpage>339</fpage><lpage>344</lpage>
<author><surname>Ward</surname> <given-names>PS</given-names> </author><author><surname>Patel</surname> <given-names>J</given-names> </author><author><surname>Wise</surname> <given-names>DR</given-names> </author><author><surname>Abdel-Wahab</surname> <given-names>O</given-names> </author><author><surname>Bennett</surname> <given-names>BD</given-names> </author><author><surname>Coller</surname> <given-names>HA</given-names> </author><author><surname>Cross</surname> <given-names>JR</given-names> </author><author><surname>Fantin</surname> <given-names>VR</given-names> </author><author><surname>Hedvat</surname> <given-names>CV</given-names> </author><author><surname>Perl</surname> <given-names>AE</given-names> </author><author><surname>Rabinowitz</surname> <given-names>JD</given-names> </author><author><surname>Carroll</surname> <given-names>M</given-names> </author><author><surname>Su</surname> <given-names>SM</given-names> </author><author><surname>Sharp</surname> <given-names>KA</given-names> </author><author><surname>Levine</surname> <given-names>RL</given-names> </author><author><surname>Thompson</surname> <given-names>CB</given-names> </author><title>The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate</title><source>Cancer Cell</source><year>2010</year><volume>17</volume><fpage>225</fpage><lpage>234</lpage>
<author><surname>Zhao</surname> <given-names>S</given-names> </author><author><surname>Lin</surname> <given-names>Y</given-names> </author><author><surname>Xu</surname> <given-names>W</given-names> </author><author><surname>Jiang</surname> <given-names>W</given-names> </author><author><surname>Zha</surname> <given-names>Z</given-names> </author><author><surname>Wang</surname> <given-names>P</given-names> </author><author><surname>Yu</surname> <given-names>W</given-names> </author><author><surname>Li</surname> <given-names>Z</given-names> </author><author><surname>Gong</surname> <given-names>L</given-names> </author><author><surname>Peng</surname> <given-names>Y</given-names> </author><author><surname>Ding</surname> <given-names>J</given-names> </author><author><surname>Lei</surname> <given-names>Q</given-names> </author><author><surname>Guan</surname> <given-names>KL</given-names> </author><author><surname>Xiong</surname> <given-names>Y</given-names> </author><title>Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha</title><source>Science</source><year>2009</year><volume>324</volume><fpage>261</fpage><lpage>265</lpage>
<author><surname>Pollard</surname> <given-names>PJ</given-names> </author><author><surname>Ratcliffe</surname> <given-names>PJ</given-names> </author><title>Cancer. Puzzling patterns of predisposition</title><source>Science</source><year>2009</year><volume>324</volume><fpage>192</fpage><lpage>194</lpage>
<author><surname>Figueroa</surname> <given-names>ME</given-names> </author><author><surname>Abdel-Wahab</surname> <given-names>O</given-names> </author><author><surname>Lu</surname> <given-names>C</given-names> </author><author><surname>Ward</surname> <given-names>PS</given-names> </author><author><surname>Patel</surname> <given-names>J</given-names> </author><author><surname>Shih</surname> <given-names>A</given-names> </author><author><surname>Li</surname> <given-names>Y</given-names> </author><author><surname>Bhagwat</surname> <given-names>N</given-names> </author><author><surname>Vasanthakumar</surname> <given-names>A</given-names> </author><author><surname>Fernandez</surname> <given-names>HF</given-names> </author><author><surname>Tallman</surname> <given-names>MS</given-names> </author><author><surname>Sun</surname> <given-names>Z</given-names> </author><author><surname>Wolniak</surname> <given-names>K</given-names> </author><author><surname>Peeters</surname> <given-names>JK</given-names> </author><author><surname>Liu</surname> <given-names>W</given-names> </author><author><surname>Choe</surname> <given-names>SE</given-names> </author><author><surname>Fantin</surname> <given-names>VR</given-names> </author><author><surname>Paietta</surname> <given-names>E</given-names> </author><author><surname>Lowenberg</surname> <given-names>B</given-names> </author><author><surname>Licht</surname> <given-names>JD</given-names> </author><author><surname>Godley</surname> <given-names>LA</given-names> </author><author><surname>Delwel</surname> <given-names>R</given-names> </author><author><surname>Valk</surname> <given-names>PJ</given-names> </author><author><surname>Thompson</surname> <given-names>CB</given-names> </author><author><surname>Levine</surname> <given-names>RL</given-names> </author><author><surname>Melnick</surname> <given-names>A</given-names> </author><title>Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation</title><source>Cancer Cell</source><year>2010</year><volume>18</volume><fpage>553</fpage><lpage>567</lpage>